Media

Media Relations

Colleen Saltmer

csaltmer@braeburnrx.com

Investor Relations

Chris Taylor

ctaylor@braeburnrx.com

Braeburn is committed to working with stakeholders and advocacy groups to improve outcomes for patients and their families.

Press Releases

Braeburn Pharmaceuticals Names Mike Derkacz as President and CEO, former Head of CNS and Pain Therapeutics for Teva PharmaceuticalsBraeburn President and CEO, Behshad Sheldon, steps down from Company and Board of Directors – Princeton, New Jersey — June 5, 2017Braeburn Pharmaceuticals, Inc. (Braeburn) announced today that Mike Derkacz has been...

Define the future at Braeburn...together.

Join Our Team